Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,260.54
2,260.08
2,841.44
2,109.84
1,389.00
1,004.31
833.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,260.54
2,260.08
2,841.44
2,109.84
1,389.00
1,004.31
833.59
Raw Material Cost
1,263.30
1,185.82
1,516.81
1,087.49
701.53
472.00
417.24
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.87
4.35
3.60
2.94
0.33
0.31
34.25
Selling and Distribution Expenses
419.88
472.01
482.91
356.51
232.74
224.34
207.61
Other Expenses
29.38
30.99
28.89
23.34
15.04
11.86
5.34
Total Expenditure (Excl Depreciation)
1,981.85
1,972.07
2,292.19
1,680.31
1,084.98
815.21
712.50
Operating Profit (PBDIT) excl Other Income
278.7
288
549.3
429.5
304
189.1
121.1
Other Income
110.06
137.09
131.54
511.21
91.25
54.50
82.61
Operating Profit (PBDIT)
514.39
531.92
739.86
990.84
417.10
254.78
217.16
Interest
4.87
4.35
3.60
2.94
0.33
0.31
34.25
Exceptional Items
7.12
2.83
-5.41
10.21
3.83
-0.70
-20.28
Gross Profit (PBDT)
997.24
1,074.26
1,324.63
1,022.35
687.47
532.32
416.35
Depreciation
122.38
104.08
64.48
51.43
23.20
12.03
12.10
Profit Before Tax
394.27
426.32
666.37
946.68
397.41
241.73
150.54
Tax
20.95
22.43
63.36
111.70
40.11
27.73
24.47
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
366.63
406.07
600.79
845.04
380.95
182.06
113.96
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
366.63
406.07
600.79
845.04
380.95
182.06
113.96
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
14.38
5.99
11.18
4.14
3.17
1.29
0.74
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
381.01
412.06
611.97
849.17
384.12
183.36
114.70
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,371.55
4,230.71
4,020.64
3,622.80
2,775.88
2,453.45
1,109.58
Earnings per share (EPS)
1.16
1.28
1.9
2.66
1.17
0.57
0.36
Diluted Earnings per share
1.16
1.28
1.9
2.66
1.17
0.57
0.36
Operating Profit Margin (Excl OI)
12.47%
12.86%
19.14%
20.3%
21.79%
18.74%
14.69%
Gross Profit Margin
22.85%
23.47%
25.72%
47.31%
30.28%
25.27%
19.51%
PAT Margin
16.22%
17.97%
21.14%
40.05%
27.43%
18.13%
13.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 0.02% vs -20.46% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -7.55% vs -32.66% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 2.41% vs -35.10% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 11.36% vs 22.22% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Qingdao Haier Biomedical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
2,260.54
0
2,260.54
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,260.54
0
2,260.54
Raw Material Cost
1,263.30
0
1,263.30
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.87
0
4.87
Selling and Distribution Expenses
419.88
0
419.88
Other Expenses
29.38
0.00
29.38
Total Expenditure (Excl Depreciation)
1,981.85
0
1,981.85
Operating Profit (PBDIT) excl Other Income
278.69
0.00
278.69
Other Income
110.06
0
110.06
Operating Profit (PBDIT)
514.39
0
514.39
Interest
4.87
0
4.87
Exceptional Items
7.12
0
7.12
Gross Profit (PBDT)
997.24
0
997.24
Depreciation
122.38
0
122.38
Profit Before Tax
394.27
0
394.27
Tax
20.95
0
20.95
Provisions and contingencies
0
0
0.00
Profit After Tax
366.63
0
366.63
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
366.63
0
366.63
Share in Profit of Associates
0
0
0.00
Minority Interest
14.38
0
14.38
Other related items
0.00
0.00
0.00
Consolidated Net Profit
381.01
0
381.01
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,371.55
0
4,371.55
Earnings per share (EPS)
1.16
0
1.16
Diluted Earnings per share
1.16
0
1.16
Operating Profit Margin (Excl OI)
12.47%
0%
0.00
12.47%
Gross Profit Margin
22.85%
0%
0.00
22.85%
PAT Margin
16.22%
0%
0.00
16.22%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 226.05 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 0.02% vs -20.46% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 38.10 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -7.55% vs -32.66% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 40.43 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 2.41% vs -35.10% in Dec 2023
Annual - Interest
Interest 0.49 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 11.36% vs 22.22% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.47%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






